Loading chat...
MA H1324
Bill
Status
2/27/2025
Primary Sponsor
Alan Silvia
Click for details
AI Summary
-
Requires pharmacy benefits managers (PBMs) to obtain a license from the Commissioner of Insurance to operate in Massachusetts, with application requirements including a surety bond and agent for service of process
-
Mandates PBMs disclose to covered entities the difference between amounts paid to pharmacies and amounts billed to plan sponsors for prescription services
-
Establishes Maximum Allowable Cost (MAC) pricing requirements, including updating pricing at least every 7 calendar days and only listing drugs rated "A" or "B" in the FDA Orange Book that are available from wholesalers
-
Creates a reimbursement appeals process allowing pharmacies to contest payment amounts within 14 business days, with PBMs required to respond within 10 business days and adjust pricing retroactively if appeals are upheld
-
Permits pharmacies to decline services if reimbursement falls below their cost, and prohibits PBMs from requiring accreditation beyond state pharmacy board or federal licensing as a condition for network participation
Legislative Description
Relative to prescription drug pricing
Last Action
Reporting date extended to Wednesday, March 18, 2026
12/8/2025